| Date Filed | Type | Description |
| 08/22/2023 |
4
| Kandera Reinhard (CFO) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Bought 7,000 shares
@ $0.725, valued at
$5.1k
|
|
| 08/17/2023 |
4
| Kandera Reinhard (CFO) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Bought 8,000 shares
@ $0.714, valued at
$5.7k
|
|
| 07/11/2023 |
4
| Aldag Jorn (CEO) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Bought 5,000 shares
@ $0.81, valued at
$4.1k
Bought 5,000 shares
@ $0.8284, valued at
$4.1k
|
|
| 07/07/2023 |
4
| Aldag Jorn (CEO) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Bought 5,000 shares
@ $0.89, valued at
$4.5k
|
|
| 07/05/2023 |
4
| Aldag Jorn (CEO) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Bought 5,000 shares
@ $0.8911, valued at
$4.5k
|
|
| 07/03/2023 |
4
| Kandera Reinhard (CFO) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Bought 12,000 shares
@ $0.88, valued at
$10.6k
|
|
| 06/09/2023 |
4
| Peters Malte (Director) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 52,000 options to buy
@ $1.01, valued at
$52.5k
|
|
| 06/09/2023 |
4
| Reilly Timothy P. (Director) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 26,000 options to buy
@ $1.01, valued at
$26.3k
|
|
| 06/09/2023 |
4
| O'Neill Julie (Director) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 26,000 options to buy
@ $1.01, valued at
$26.3k
|
|
| 06/09/2023 |
4
| van de Winkel Jan (Director) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 52,000 options to buy
@ $1.01, valued at
$52.5k
|
|
| 06/09/2023 |
4
| Kaufman David Ross (Director) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 26,000 options to buy
@ $1.01, valued at
$26.3k
|
|
| 06/09/2023 |
4
| Coelho Mary Theresa (Director) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 52,000 options to buy
@ $1.01, valued at
$52.5k
|
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/18/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/04/2023 |
3
| Coelho Mary Theresa (Director) has filed a Form 3 on HOOKIPA Pharma Inc. |
| 07/01/2022 |
4
| van de Winkel Jan (Director) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.63, valued at
$65.2k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Orlinger Klaus (Chief Scientific Officer) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 48,350 options to buy
@ $1.66, valued at
$80.3k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Necina Roman (Chief Technology Officer) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 48,350 options to buy
@ $1.66, valued at
$80.3k
|
|
| 07/01/2022 |
4
| Matushansky Igor (Chief Medical Officer) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 92,950 options to buy
@ $1.66, valued at
$154.3k
|
|
| 07/01/2022 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.63, valued at
$32.6k
|
|
| 07/01/2022 |
4
| Kaufman David Ross (Director) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.63, valued at
$32.6k
|
|
| 07/01/2022 |
4
| Kandera Reinhard (CFO) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 92,950 options to buy
@ $1.66, valued at
$154.3k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2022 |
4
| Orlinger Klaus (Chief Scientific Officer) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 48,350 options to buy
@ $1.66, valued at
$80.3k
|
|
| 04/20/2022 |
4
| Necina Roman (Chief Technology Officer) has filed a Form 4 on HOOKIPA Pharma Inc.|
Txns:
| Granted 48,350 options to buy
@ $1.66, valued at
$80.3k
|
|
|